BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4042431)

  • 1. Interaction of mutant lpr gene with background strain influences renal disease.
    Kelley VE; Roths JB
    Clin Immunol Immunopathol; 1985 Nov; 37(2):220-9. PubMed ID: 4042431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis.
    Yoshida H; Yoshida M; Izui S; Lambert PH
    J Clin Invest; 1985 Aug; 76(2):685-94. PubMed ID: 3875630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
    J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced response of macrophages to CSF-1 in autoimmune mice: a gene transfer strategy.
    Moore KJ; Naito T; Martin C; Kelley VR
    J Immunol; 1996 Jul; 157(1):433-40. PubMed ID: 8683149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different expression of T-cell receptor beta-chain variable region genes in lymph nodes of lpr mice with different alleles of the major histocompatibility complex.
    Ohga S; Yoshikai Y; Kishihara K; Matsuzaki G; Ogimoto M; Nomoto K
    Immunology; 1990 Jun; 70(2):216-22. PubMed ID: 2373519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
    Izui S; Kelley VE; Masuda K; Yoshida H; Roths JB; Murphy ED
    J Immunol; 1984 Jul; 133(1):227-33. PubMed ID: 6609979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease.
    Moore KJ; Yeh K; Naito T; Kelley VR
    J Immunol; 1996 Jul; 157(1):427-32. PubMed ID: 8683148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological characteristics of the kidney in recombinant inbred mice established from MRL/lpr x AKR crossing. Dissociation of severity of lupus nephritis from the degree of lymphadenopathy.
    Makino M; Morita T; Fujiwara M
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(1):59-65. PubMed ID: 2907203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the role of the lpr gene in the development of immunological abnormalities and lupus nephritis. Analyses in F2 mice.
    Fujiwara M; Kariyone A; Shiraki M
    Clin Exp Immunol; 1985 Jan; 59(1):161-8. PubMed ID: 3918816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK; Jarmi T; Ruiz P; Xu Y; Holers VM; Gilkeson GS
    Kidney Int; 2004 Jan; 65(1):129-38. PubMed ID: 14675043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
    Santiago-Raber ML; Haraldsson MK; Theofilopoulos AN; Kono DH
    J Immunol; 2007 Jun; 178(12):8195-202. PubMed ID: 17548658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R; Shibata T; De Kossodo S; Izui S
    Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of the germ-line VH gene corresponding to a nephritogenic antibody in MRL/lpr lupus mice.
    Ono M; Yamamoto T; Kyogoku M; Nose M
    Clin Exp Immunol; 1995 May; 100(2):284-90. PubMed ID: 7743668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
    Ratkay LG; Tait B; Tonzetich J; Waterfield JD
    J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephritogenicity of the lprcg gene on the MRL background.
    Kimura M; Ogata Y; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A
    Immunology; 1992 Jul; 76(3):498-504. PubMed ID: 1526655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.